VLCC to market CMFRI’s anti-obesity product

The Central Marine Fisheries Research Institute (CMFRI) has given VLCC the exclusive licence to use its recently-developed anti-obesity nutraceutical product CadalminTM Antihypercholesterolemic extrac

Published: 28th May 2017 10:32 PM  |   Last Updated: 29th May 2017 04:49 AM   |  A+A-

By Express News Service

KOCHI: The Central Marine Fisheries Research Institute (CMFRI) has given VLCC the exclusive licence to use its recently-developed anti-obesity nutraceutical product CadalminTM Antihypercholesterolemic extract (CadalminTM ACe) for commercial production and marketing.

CMFRI director A Gopalakrishnan signed a licence agreement with VLCC Group director Sandeep Ahuja and executive vice-president (research and development) A H Zaidi. After years of intensive research, the CMFRI developed the nutraceutical product using natural marine bio-active ingredients from select seaweeds. The product was found effective in combating obesity and dyslipidemia, an abnormal amount of lipids in the blood.

Gopalakrishnan said the product provided a unique blend of 100 per cent natural marine bio-active ingredients from selected seaweeds with an eco-friendly ‘green technology’, which is under patent.
“Detailed pre-clinical trials have established the product is devoid of any side-effects even in long-term oral administration of tablets. The product is prepared from seaweeds which are known for their medicinal properties and are commonly available in the Indian coast,” he said.
“CadalminTM ACe is the fourth in the series of the nutraceutical products developed by CMFRI from seaweeds,” he said.

The CMFRI, which has already developed nutraceuticals for diabetes and arthritis, is in the process of developing more health products and nutraceuticals from seaweeds found in abundance in the country’s coastal waters,” Gopalakrishnan said.

Stay up to date on all the latest Kochi news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp